Navellier & Associates’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$272K Hold
2025
Q1
$304K Sell
2024
Q4
$296K Buy
2024
Q3
$244K Sell
2024
Q2
$217K Buy
2024
Q1
$220K Sell
2023
Q4
$2.59M Buy
2023
Q3
$1.6M Buy
2023
Q2
$1.69M Buy
2023
Q1
$2.07M Buy
2022
Q4
$2.04M Buy
2022
Q3
$1.35M Buy